CFTR-deficient pigs display peripheral nervous system defects at birth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 8, 2013, Pages 3083-3088

  Reznikov, Leah R ^a   Dong, Qian ^a   Chen, Jeng Haur ^a   Moninger, Thomas O ^a   Park, Jung Min ^a   Zhang, Yuzhou ^a   Du, Jianyang ^a   Hildebrand, Michael S ^a   Smith, Richard J H ^a   Randak, Christoph O ^a   Stoltz, David A ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MYELIN PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DENSITY; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; EVOKED BRAIN STEM AUDITORY RESPONSE; GENE DISRUPTION; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MALE; MYELIN SHEATH; NERVE CONDUCTION; NERVE FIBER; NERVOUS SYSTEM FUNCTION; NEWBORN; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SCIATIC NERVE; SWINE; TRIGEMINAL NERVE; VESTIBULOCOCHLEAR NERVE;

ANIMALS; ANIMALS, NEWBORN; AXONS; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; MALE; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM; POLYMERASE CHAIN REACTION; SWINE;

EID: 84874235716     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222729110     Document Type: Article

References (60)

1. Welsh MJ, Ramsey BW, Accurso F, Cutting GR (2001) Cystic fibrosis. The Metabolic and Molecular Basis of Inherited Disease, eds Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (McGraw-Hill, New York), 8th Ed, pp5121-5189.
2. Quinton PM (1999) Physiological basis of cystic fibrosis: A historical perspective. Physiol Rev 79 (1):Suppl):S3-S22.
3. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352 (19):1992-2001.
4. El-Salem K, Aburahma S, Rawashdeh M (2010) Peripheral nerve dysfunction in patients with cystic fibrosis. J Clin Neurophysiol 27 (3):216-218.
5. O'Riordan JI, Hayes J, Fitzgerald MX, Redmond J (1995) Peripheral nerve dysfunction in adult patients with cystic fibrosis. Ir J Med Sci 164 (3):207-208.
6. Heinz-Erian P, Dey RD, Flux M, Said SI (1985) Deficient vasoactive intestinal peptide in-nervation in the sweat glands of cystic fibrosis patients. Science 229 (4720):1407-1408.
7. Bentur L, et al. (2006) Impaired gastric myolectrical activity in patients with cystic fi-brosis. J Cyst Fibros 5 (3):187-191.
8. Davis PB, Kaliner M (1983) Autonomic nervous system abnormalities in cystic fibrosis. J Chronic Dis 36 (3):269-278.
9. Davis PB, Shelhamer JR, Kaliner M (1980) Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis. N Engl J Med 302 (26):1453-1456.
10. Vaisman N, Tabachnik E, Shahar E, Gilai A (1996) Impaired brainstem auditory evoked potentials in patients with cystic fibrosis. Dev Med Child Neurol 38 (1):59-64.
11. Staley K, Iragui VJ (1991) Somatosensory dysfunction in cystic fibrosis. Eur Neurol 31 (2):77-81.
12. Bureau MA, Lupien L, Bégin R (1981) Neural drive and ventilatory strategy of breathing in normal children, and in patients with cystic fibrosis and asthma. Pediatrics 68 (2):187-194.
13. Gild R, Clay CD, Morey S (2010) Aquagenic wrinkling of the palms in cystic fibrosis and the cystic fibrosis carrier state: A case-control study. Br J Dermatol 163 (5):1082-1084.
14. Patel AJ, Raol VH, Jea A (2011) Rare association between cystic fibrosis, Chiari I malformation, and hydrocephalus in a baby: A case report and review of the literature. J Med Case Reports 5:366.
15. Liu GJ, Kalous A, Werry EL, Bennett MR (2006) Purine release from spinal cord mi-croglia after elevation of calcium by glutamate. Mol Pharmacol 70 (3):851-859.
16. Mulberg AE, et al. (1994) Cystic fibrosis transmembrane conductance regulator protein expression in brain. Neuroreport 5 (13):1684-1688.
17. McGrath SA, Basu A, Zeitlin PL (1993) Cystic fibrosis gene and protein expression during fetal lung development. Am J Respir Cell Mol Biol 8 (2):201-208.
18. Niu N, Zhang J, Guo Y, Yang C, Gu J (2009) Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia. Lab Invest 89 (6):636-644.
19. Davis PB (1984) Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 129 (6):911-914.
20. Rogers CS, et al. (2008) Production of CFTR null and ΔF508 heterozygous pigs by AAV-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118 (4):1571-1577.
21. Rogers CS, et al. (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321 (5897):1837-1841.
22. Stoltz DA, et al. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2 (29):29ra31.
23. Muanprasat C, et al. (2004) Discovery of glycine hydrazide pore-occluding CFTR inhibitors: Mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124 (2):125-137.
24. Fabrizi GM, et al. (2000) Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero. Acta Neuropathol 100 (3):299-304.
25. Gambardella A, et al. (1998) Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Neurology 50 (3):799-801.
26. Tersar K, et al. (2007) Mtmr13/Sbf2-deficient mice: An animal model for CMT4B2. Hum Mol Genet 16 (24):2991-3001.
27. Quattrone A, et al. (1996) Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: Clinical, electrophysiologic, and genetic aspects of a large family. Neurology 46 (5):1318-1324.
28. Patzko A, Shy ME (2012) Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum (Minneap Minn) 18 (1):39-59.
29. Maeda MH, et al. (2012) Increased gene dosage of myelin protein zero causes Char-cot-Marie-Tooth disease. Ann Neurol 71 (1):84-92.
30. Fratta P, et al. (2011) P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice. Hum Mol Genet 20 (11):2081-2090.
31. Rünker AE, et al. (2004) Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder. J Cell Biol 165 (4):565-573.
32. Nobbio L, et al. (2009) P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy. J Biol Chem 284 (34):23146-23158.
33. Wrabetz L, et al. (2000) P (0) glycoprotein overexpression causes congenital hypo-myelination of peripheral nerves. J Cell Biol 148 (5):1021-1034.
34. Eberhard DA, Brown MD, Van den Berg SR (1994) Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of an-nexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol 145 (3):640-649.
35. Shames I, Fraser A, Colby J, Orfali W, Snipes GJ (2003) Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases. J Neuropathol Exp Neurol 62 (7):751-764.
36. Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A (1999) Axonal pheno-type of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 66 (6):779-782.
37. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI (1996) Auditory neuropathy. Brain 119 (Pt 3):741-753.
38. Høyer H, Braathen GJ, Eek AK, Skjelbred CF, Russell MB (2011) Charcot-Marie-Tooth caused by a copy number variation in myelin protein zero. Eur J Med Genet 54 (6): e580-e583.
39. Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA (2000) Uncoupling of myelin assembly and Schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J Neurosci 20 (11):4120-4128.
40. Hattori N, et al.; Study Group for Hereditary Neuropathy in Japan (2003) De-myelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 126 (Pt 1):134-151.
41. Misu K, et al. (2000) An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 69 (6):806-811.
42. Cynamon HA, Milov DE, Valenstein E, Wagner M (1988) Effect of vitamin E deficiency on neurologic function in patients with cystic fibrosis. J Pediatr 113 (4):637-640.
43. Ramirez JD, Barnes PR, Mills KR, Bennett DL (2012) Intermediate Charcot-Marie-Tooth disease due to a novel Trp101Stop myelin protein zero mutation associated with debilitating neuropathic pain. Pain 153 (8):1763-1768.
44. Mastaglia FL, et al. (1999) Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 67 (2):174-179.
45. Kraus A, et al. (2010) Calnexin deficiency leads to dysmyelination. J Biol Chem 285 (24):18928-18938.
46. Wilkins A, et al. (2010) Slowly progressive axonal degeneration in a rat model of chronic, nonimmune-mediated demyelination. J Neuropathol Exp Neurol 69 (12):1256-1269.
47. Wilson GF, Chiu SY (1993) Mitogenic factors regulate ion channels in Schwann cells cultured from newborn rat sciatic nerve. J Physiol 470:501-520.
48. Byun N, Delpire E (2007) Axonal and periaxonal swelling precede peripheral neuro-degeneration in KCC3 knockout mice. Neurobiol Dis 28 (1):39-51.
49. Lind NM, et al. (2007) The use of pigs in neuroscience: Modeling brain disorders. Neurosci Biobehav Rev 31 (5):728-751.
50. Borovikova LV, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (6785):458-462.
51. Chmiel JF, Konstan MW (2007) Inflammation and anti-inflammatory therapies for cystic fibrosis. Clin Chest Med 28 (2):331-346.
52. Wine JJ, Joo NS (2004) Submucosal glands and airway defense. Proc Am Thorac Soc 1 (1):47-53.
53. Burns AJ, Roberts RR, Bornstein JC, Young HM (2009) Development of the enteric nervous system and its role in intestinal motility during fetal and early postnatal stages. Semin Pediatr Surg 18 (4):196-205.
54. De Giorgio R, et al. (2004) New insights into human enteric neuropathies. Neuro-gastroenterol Motil 16 (Suppl 1):143-147.
55. Davidson AC, Harrison K, Steinfort CL, Geddes DM (1987) Distal intestinal obstruction syndrome in cystic fibrosis treated by oral intestinal lavage, and a case of recurrent obstruction despite normal pancreatic function. Thorax 42 (7):538-541.
56. Rogan MP, et al. (2010) Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth. Proc Natl Acad Sci USA 107 (47):20571-20575.
57. Ullian EM, Harris BT, Wu A, Chan JR, Barres BA (2004) Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci 25 (2):241-251.
58. Dubowitz V, Lane R, Sewry CA (2007) Muscle Biopsy: A Practical Approach (Saunders Elsevier, Philadelphia), 3rd Ed.
59. Velumian AA, Wan Y, Samoilova M, Fehlings MG (2010) Modular double sucrose gap apparatus for improved recording of compound action potentials from rat and mouse spinal cord white matter preparations. J Neurosci Methods 187 (1):33-40.
60. Ruxton GD, Beauchamp GK (2008) Time for some a priori thinking about post hoc testing. Behav Ecol 19 (3):690-693.